Obligatory Responses to FDA Inspection Outcomes and Future Drug Shortages

References

• Ahuja V, Alvarez CA, Birge JR, Syverson C (2021) Enhancing regulatory decision making for postmarket drug safety. Management Sci. 67(12):7493–7510.Link, Google Scholar
• Anand G, Mukherjee UK (2024) Learning from failures: Differentiating between slip-ups and knowledge gaps. Organization Sci. 35(6):2095–2116.Google Scholar
• Anand G, Gray J, Siemsen E (2012) Decay, shock, and renewal: Operational routines and process entropy in the pharmaceutical industry. Organ. Sci. 23(6):1700–1716.Link, Google Scholar
• Ball G, Siemsen E, Shah R (2017) Do plant inspections predict future quality? The role of investigator experience. Manufacturing Service Oper. Management 19(4):534–550.Link, Google Scholar
• Ball GP, Bavafa H, Blanco CC, Park H, Wowak KD (2024) Gender and serious drug recalls: A textual sentiment analysis of drug reviews on WebMD. Production Oper. Management, ePub ahead of print May 9, https://doi.org/10.1177/10591478241256644.Crossref, Google Scholar
• Campbell HR, Lodder RA (2021) A brief review of FDA’s novel tools for ensuring pharmaceutical quality in the human drug supply chain. CIC Pharm. Sci. 1:1–10.Google Scholar
• Chapman B (2023) Students struggle academically, fight in schools amid Adderall shortage. Wall Street J. (March 24), https://www.wsj.com/articles/students-struggle-academically-fight-in-schools-amid-adderall-shortage-209d01e0.Google Scholar
• Choo EK, Rajkumar SV (2020) Medication shortages during the COVID-19 crisis: What we must do. Mayo Clinic Proc. 95(6):1112–1115.Crossref, Google Scholar
• Dai H, Milkman KL, Riis J (2014) The fresh start effect: Temporal landmarks motivate aspirational behavior. Management Sci. 60(10):2563–2582.Link, Google Scholar
• de Vries H, Jahre M, Selviaridis K, van Oorschot KE, Van Wassenhove LN (2021) Short of drugs? Call upon operations and supply chain management. Internat. J. Oper. Production Management 41(10):1569–1578.Crossref, Google Scholar
• Diestre L, Barber IB, Santalo J (2020) The Friday effect: Firm lobbying, the timing of drug safety alerts, and drug side effects. Management Sci. 66(8):3677–3698.Link, Google Scholar
• Dong Y, Lewbel A (2015) A simple estimator for binary choice models with endogenous regressors. Econometric Rev. 34(1–2):82–105.Crossref, Google Scholar
• FDA (2013) Strategic plan for preventing and mitigating drug shortages. Accessed March 1, 2025, https://www.fda.gov/media/86907/download.Google Scholar
• FDA (2018) Understanding CDER’s risk-based site selection model. Accessed December 20, 2020, https://www.fda.gov/media/118214/download.Google Scholar
• FDA (2019a) Drug shortages: Root causes and potential solutions. Accessed March 1, 2025, https://www.fda.gov/media/131130/download.Google Scholar
• FDA (2019b) FDA offices across the country. Accessed July 24, 2024, https://www.fda.gov/about-fda/jobs-and-training-fda/text-description-map-showing-fda-offices-across-country.Google Scholar
• FDA (2021a) Drug shortages for calendar year 2020: Report to Congress. Accessed March 1, 2025, https://www.fda.gov/media/150409/download.Google Scholar
• FDA (2021b) Investigations operations manual. Accessed March 1, 2025, https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-references/investigations-operations-manual.Google Scholar
• Fink S (2016) Drug shortages forcing hard decisions on rationing treatments. New York Times (January 29), https://www.nytimes.com/2016/01/29/us/drug-shortages-forcing-hard-decisions-on-rationing-treatments.html.Google Scholar
• Fox E, Tyler L (2013) Call to action: Finding solutions for the drug shortage crisis in the United States. Clin. Pharmacology Therapeutics 93(2):145–147.Crossref, Google Scholar
• Fox ER, Stolbach AI, Mazer-Amirshahi M (2020) The landscape of prescription drug shortages during the COVID-19 pandemic. J. Medical Toxicology 16(3):311–313.Crossref, Google Scholar
• Fox ER, Sweet BV, Jensen V (2014) Drug shortages: A complex health care crisis. Mayo Clinic Proc. 89(3):361–373.Crossref, Google Scholar
• Fox ER, Birt A, James KB, Kokko H, Salverson S, Soflin DL (2009) ASHP guidelines on managing drug product shortages in hospitals and health systems. Amer. J. Health-System Pharmacy 66(15):1399–1406.Crossref, Google Scholar
• GAO (2016) Drug shortages GAO-16-595. Accessed March 1, 2025, https://www.gao.gov/assets/680/678363.pdf.Google Scholar
• Gong B, Pan D, Shi D (2017) New investors and bubbles: An analysis of the Baosteel call warrant bubble. Management Sci. 63(8):2493–2508.Link, Google Scholar
• Gray JV, Roth AV, Leiblein MJ (2011) Quality risk in offshore manufacturing: Evidence from the pharmaceutical industry. J. Oper. Management 29(7–8):737–752.Crossref, Google Scholar
• Gupta D, Huang SM (2013) Drug shortages in the United States: A critical evaluation of root causes and the need for action. Clinical Pharmacology Therapeutics 93(2):133–135.Crossref, Google Scholar
• Han L, Fine J, Robinson SM, Boyle AA, Freeman M, Scholtes S (2019) Is seniority of emergency physician associated with the weekend mortality effect? An exploratory analysis of electronic health records in the UK. Emergency Medicine J. 36(12):708–715.Crossref, Google Scholar
• Hernandez I, Hershey TB, Donohue JM (2020) Drug shortages in the United States: Are some prices too low? JAMA 323(9):819–820.Crossref, Google Scholar
• Ibanez MR, Clark JR, Huckman RS, Staats BR (2018) Discretionary task ordering: Queue management in radiological services. Management Sci. 64(9):4389–4407.Link, Google Scholar
• Jia J, Zhao H (2017) Mitigating the US drug shortages through pareto-improving contracts. Production Oper. Management 26(8):1463–1480.Crossref, Google Scholar
• Kweder SL, Dill S (2013) Drug shortages: The cycle of quantity and quality. Clinical Pharmacology Therapeutics 93(3):245–251.Crossref, Google Scholar
• Laurencin CT, Nair L (2008) The FDA and safety—Beyond the heparin crisis. Nature Biotechnology 26(6):621–623.Crossref, Google Scholar
• Lawrence XY, Woodcock J (2015) FDA pharmaceutical quality oversight. Internat. J. Pharmaceutics 491(1–2):2–7.Crossref, Google Scholar
• Lee J, Lee HS, Shin H, Krishnan V (2021) Alleviating drug shortages: The role of mandated reporting induced operational transparency. Management Sci. 67(4):2326–2339.Link, Google Scholar
• Lewbel A (2000) Semiparametric qualitative response model estimation with unknown heteroscedasticity or instrumental variables. J. Econometrics 97(1):145–177.Crossref, Google Scholar
• Lichtenberg FR, Philipson TJ (2002) The dual effects of intellectual property regulations: Within-and between-patent competition in the US pharmaceuticals industry. J. Law Econom. 45(S2):643–672.Crossref, Google Scholar
• Lim JM, Song H, Yang J (2022) The spillover effects of capacity pooling in hospitals. Management Sci. 70(11):7692–7711.Google Scholar
• Loftus P (2014) Pfizer will resume shipping thyroid drug. Wall Street J. (February 21), https://www.wsj.com/articles/SB10001424052702303636404579397443842350248.Google Scholar
• Macher JT, Mayo JW, Nickerson JA (2011) Regulator heterogeneity and endogenous efforts to close the information asymmetry gap. J. Law Econom. 54(1):25–54.Crossref, Google Scholar
• McCaffrey DP, Smith AE, Martinez-Moyano IJ (2007) “Then let’s have a dialogue”: Interdependence and negotiation in a cohesive regulatory system. J. Public Admin. Res. Theory 17(2):307–334.Crossref, Google Scholar
• Merritt RJ, Goldsmith AH (2014) Scientific, economic, regulatory, and ethical challenges of bringing science-based pediatric nutrition products to the US market and ensuring their availability for patients. J. Parenteral Enteral Nutrition 38(2S):17S–34S.Crossref, Google Scholar
• Mitka M (2012) FDA role in drug shortages. JAMA 308(6):558–558.Google Scholar
• Monga V (2022) Canada confronts shortage of children’s pain relievers. Wall Street J. (November 11), https://www.wsj.com/articles/canada-confronts-shortage-of-childrens-pain-relievers-11668177013.Google Scholar
• NASEM (2022) Building Resilience into the Nation’s Medical Product Supply Chains (The National Academies Press, Washington, DC).Google Scholar
• Park M, Carson AL, Fox ER, Conti RM (2024) Stockpiling at the onset of the COVID-19 pandemic: An empirical analysis of national prescription drug sales and prices. Management Sci. 70(10):6483–6501.Link, Google Scholar
• Perspective Press (2016) The Pharmacy Technician, 6th ed. (Morton Publishing Company, Denver).Google Scholar
• Racine J, Su L, Ullah A, eds. (2014) Handbook of Applied Nonparametric and Semiparametric Econometrics and Statistics (Oxford University Press, Oxford, UK).Crossref, Google Scholar
• Roman A (2013) The FDA and the pharmaceutical industry: Is regulation contributing to drug shortages? Albany Law Rev. 77(2):539–577.Google Scholar
• Roy A (2012) How Margaret Hamburg’s FDA causes cancer drug shortages. Forbes (June 15), https://www.forbes.com/sites/theapothecary/2012/06/15/how-margaret-hamburgs-fda-causes-cancer-drug-shortages/?sh=2d999814a036.Google Scholar
• Schweitzer SO (2013) How the US Food and Drug Administration can solve the prescription drug shortage problem. Amer. J. Public Health 103(5):e10–e14.Crossref, Google Scholar
• Shukar S, Zahoor F, Hayat K, Saeed A, Gillani AH, Omer S, Hu S, Babar ZUD, Fang Y, Yang C (2021) Drug shortage: Causes, impact, and mitigation strategies. Frontiers Pharmacology 12:693426.Crossref, Google Scholar
• Song H, Tucker AL, Graue R, Moravick S, Yang JJ (2020) Capacity pooling in hospitals: The hidden consequences of off-service placement. Management Sci. 66(9):3825–3842.Link, Google Scholar
• Sotak KL, Moxley TR, Todd S, Yearwood S, Privitera GJ (2020) Productivity: Time of day, day of week, and morningness effects. BRC Acad. J. Medicine 8(1):85–111.Google Scholar
• Sullivan T (2012) House committee on oversight and government reform report: FDA’s contribution to the drug shortage crisis. Policy Medicine (May 6), https://www.policymed.com/2012/06/house-committee-on-oversight-and-government-reform-report-fdas-contribution-to-the-drug-shortage-crisis.html.Google Scholar
• Tavernise S (2014) Drug shortages continue to vex doctors. New York Times (February 10), https://www.nytimes.com/2014/02/11/health/shortages-of-critical-drugs-continue-to-vex-doctors-study-finds.html.Google Scholar
• Thirumalai S, Sinha KK (2011) Product recalls in the medical device industry: An empirical exploration of the sources and financial consequences. Management Sci. 57(2):376–392.Link, Google Scholar
• Tucker EL, Cao Y, Fox ER, Sweet BV (2020a) The drug shortage era: A scoping review of the literature 2001–2019. Clinical Pharmacology Therapeutics 108(6):1150–1155.Crossref, Google Scholar
• Tucker EL, Daskin MS, Sweet BV, Hopp WJ (2020b) Incentivizing resilient supply chain design to prevent drug shortages: Policy analysis using two-and multi-stage stochastic programs. IISE Trans. 52(4):394–412.Crossref, Google Scholar
• U.S. Senate (2012) S.3187 - Food and Drug Administration Safety and Innovation Act. Accessed March 1, 2025, http://congress.gov/bill/112th-congress/senate-bill/3187.Google Scholar
• Ventola CL (2011) The drug shortage crisis in the United States: Causes, impact, and management strategies. Pharmacy Therapeutics 36(11):740–757.Google Scholar
• Wall Street Journal (2023) Why cancer drugs are being rationed. Wall Street J. (May 22), https://www.wsj.com/articles/drug-shortages-price-controls-government-fda-white-house-cancer-treatments-b2d08ba4.Google Scholar
• Wang K, Li Y, Erickson J (1997) A new look at the Monday effect. J. Finance 52(5):2171–2186.Crossref, Google Scholar
• Woodcock J, Wosinska M (2013) Economic and technological drivers of generic sterile injectable drug shortages. Clinical Pharmacology Therapeutics 93(2):170–176.Google Scholar
• Wooldridge JM (2015) Control function methods in applied econometrics. J. Human Resources 50(2):420–445.Crossref, Google Scholar
• Yurukoglu A, Liebman E, Ridley DB (2017) The role of government reimbursement in drug shortages. Amer. Econom. J. Econom. Policy 9(2):348–382.Crossref, Google Scholar